Literature DB >> 21453736

The activity of antimicrobial peptide S-thanatin is independent on multidrug-resistant spectrum of bacteria.

Guoqiu Wu1, Xiaofang Li, Xiaobo Fan, Hongbin Wu, Shenglan Wang, Zilong Shen, Tao Xi.   

Abstract

In this study, the activity of S-thanatin (an analog of antimicrobial peptide derived from thanatin) against different bacterial pathogens frequently which can cause therapeutic problems was tested. The result showed minimal inhibitory concentrations (MICs) of S-thanatin against all isolates of the Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Enterobacter aerogenes, Klebsiella ornithinolytica and Klebsiella oxytoca were in the range of 4-16μg/ml, no matter which antibiotic the bacterial was resistant or susceptible, while almost all MICs to Gram-positive bacterial were >128μg/ml except Enterococcus faecium. S-thanatin was more effective toward Gram-negative strains, especially for Enterobacter and Klebsiella. The MICs of S-thanatin were no significantly different in the same species regardless of antibiotic sensitive or -resistant isolates to single or multiple antibiotic (P>0.05). Likewise, no notable difference could be observed between E. coli, K. pneumoniae, E. cloacae, E. aerogenes, K. ornithinolytica which were sensitive to S-thanatin (P>0.05). It was implied that the antimicrobial activity of S-thanatin was independent on multi-drug resistance spectrum of bacteria.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21453736     DOI: 10.1016/j.peptides.2011.03.019

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  12 in total

1.  Thanatin confers partial resistance against aflatoxigenic fungi in maize (Zea mays).

Authors:  Max Schubert; Marcel Houdelet; Karl-Heinz Kogel; Rainer Fischer; Stefan Schillberg; Greta Nölke
Journal:  Transgenic Res       Date:  2015-06-13       Impact factor: 2.788

Review 2.  On the role of NMR spectroscopy for characterization of antimicrobial peptides.

Authors:  Fernando Porcelli; Ayyalusamy Ramamoorthy; George Barany; Gianluigi Veglia
Journal:  Methods Mol Biol       Date:  2013

3.  Antibacterial effects assessment on some livestock pathogens, thermal stability and proposing a probable reason for different levels of activity of thanatin.

Authors:  Ali Javadmanesh; Elyas Mohammadi; Zahra Mousavi; Marjan Azghandi; Abass Tanhaiean
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

4.  A Hybrid Peptide PTS that Facilitates Transmembrane Delivery and Its Application for the Rapid In vivo Imaging via Near-Infrared Fluorescence Imaging.

Authors:  Xuejiao Yan; Guoqiu Wu; Qingrong Qu; Xiaobo Fan; Xudong Xu; Naifeng Liu
Journal:  Front Pharmacol       Date:  2016-03-08       Impact factor: 5.810

5.  Antifungal activity of recombinant thanatin in comparison with two plant extracts and a chemical mixture to control fungal plant pathogens.

Authors:  Mojtaba Mamarabadi; Abbas Tanhaeian; Younes Ramezany
Journal:  AMB Express       Date:  2018-11-02       Impact factor: 3.298

Review 6.  Antimicrobial peptides: new hope in the war against multidrug resistance.

Authors:  James Mwangi; Xue Hao; Ren Lai; Zhi-Ye Zhang
Journal:  Zool Res       Date:  2019-11-18

7.  Expression of Thanatin in HEK293 Cells and Investigation of its Antibacterial Effects on Some Human Pathogens.

Authors:  Abbas Tanhaeian; Marjan Azghandi; Zahra Mousavi; Ali Javadmanesh
Journal:  Protein Pept Lett       Date:  2020       Impact factor: 1.890

8.  Identification of a Novel Proline-Rich Antimicrobial Peptide from Brassica napus.

Authors:  Huihui Cao; Tao Ke; Renhu Liu; Jingyin Yu; Caihua Dong; Mingxing Cheng; Junyan Huang; Shengyi Liu
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

Review 9.  Focal Targeting of the Bacterial Envelope by Antimicrobial Peptides.

Authors:  Rafi Rashid; Mark Veleba; Kimberly A Kline
Journal:  Front Cell Dev Biol       Date:  2016-06-07

10.  S-thanatin functionalized liposome potentially targeting on Klebsiella pneumoniae and its application in sepsis mouse model.

Authors:  Xiaobo Fan; Juxiang Fan; Xiyong Wang; Pengpeng Wu; Guoqiu Wu
Journal:  Front Pharmacol       Date:  2015-10-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.